Financial News
Articles published by Biora Therapeutics, Inc.
Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform
September 05, 2023
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 14, 2023
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platform
August 03, 2023
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update
July 17, 2023
Via GlobeNewswire
Tickers
BIOR
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform
June 28, 2023
Via GlobeNewswire
Tickers
BIOR
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Participate in Crohn’s & Colitis Foundation’s IBD Innovate Conference
April 20, 2023
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist
February 23, 2023
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Improved Bioavailability Results for its Systemic Delivery Platform
February 16, 2023
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
January 09, 2023
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Two Poster Presentations at the Crohn’s & Colitis Congress
December 08, 2022
Via GlobeNewswire
Tickers
BIOR
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 14, 2022
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update
November 07, 2022
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces $9.75 Million Direct Offering
November 07, 2022
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
October 27, 2022
Via GlobeNewswire
Tickers
BIOR
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
October 25, 2022
Via GlobeNewswire
Tickers
BIOR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.